GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Ananda Pharma PLC (STU:1FX) » Definitions » Short-Term Debt

Ananda Pharma (STU:1FX) Short-Term Debt : €0.81 Mil (As of Jul. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Ananda Pharma Short-Term Debt?

Ananda Pharma's Short-Term Debt for the quarter that ended in Jul. 2024 was €0.81 Mil.

Ananda Pharma's quarterly Short-Term Debt declined from Jan. 2023 (€4.18 Mil) to Jul. 2023 (€0.00 Mil) but then increased from Jul. 2023 (€0.00 Mil) to Jul. 2024 (€0.81 Mil).

Ananda Pharma's annual Short-Term Debt increased from Jan. 2021 (€0.30 Mil) to Jan. 2022 (€1.20 Mil) and increased from Jan. 2022 (€1.20 Mil) to Jan. 2023 (€4.18 Mil).

Ananda Pharma Short-Term Debt Historical Data

The historical data trend for Ananda Pharma's Short-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ananda Pharma Short-Term Debt Chart

Ananda Pharma Annual Data
Trend Jan19 Jan20 Jan21 Jan22 Jan23
Short-Term Debt
- 0.10 0.30 1.20 4.18

Ananda Pharma Semi-Annual Data
Jul18 Jan19 Jul19 Jan20 Jul20 Jan21 Jul21 Jan22 Jul22 Jan23 Jul23 Jul24
Short-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.20 - 4.18 - 0.81

Ananda Pharma Short-Term Debt Explanation

Short-Term Debt represents the total amount of Long-Term Debt such as bank loans and commercial paper, which is due within one year.

Ananda Pharma Short-Term Debt Related Terms

Thank you for viewing the detailed overview of Ananda Pharma's Short-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Ananda Pharma Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Ananda Pharma PLC (STU:1FX) » Definitions » Short-Term Debt
Comparable Companies
LSE:HELD LSE:N4P LSE:PXS LSE:CHLL ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 SZSE:000538 XSWX:SDZ HKSE:03692 NSE:DIVISLAB BOM:500124 VTRS NBIX SZSE:000963 SHSE:600085
Traded in Other Exchanges
ANA:UK
Address
60 Gracechurch Street, 6th Floor, London, GBR, EC3V 0HR
Website
https://www.anandapharma.co.uk
Ananda Pharma PLC is focused on the development of cannabinoid therapies for the treatment of a range of complex conditions. The company is developing NHS-approved and MHRA-licensed cannabinoid medicines for the treatment of drug-resistant epilepsies and specific inflammatory pain conditions (starting with CIPN & endometriosis) and HFpEF heart failure.

Ananda Pharma Headlines

No Headlines